Scarica l'app Stockscreener
3.027
0.43%
-0.013
Dopo l'orario di chiusura:
3.03
0.003
+0.10%
Precedente Chiudi:
$3.04
Aprire:
$3.05
Volume 24 ore:
6,335
Relative Volume:
0.13
Capitalizzazione di mercato:
$16.40M
Reddito:
-
Utile/perdita netta:
$-16.35M
Rapporto P/E:
-0.9925
EPS:
-3.05
Flusso di cassa netto:
$-11.88M
1 W Prestazione:
+3.31%
1M Prestazione:
+0.90%
6M Prestazione:
-16.61%
1 anno Prestazione:
-17.30%
Intervallo 1D:
$3.01
$3.0501
Intervallo di 1 settimana:
$2.86
$3.10
Portata 52W:
$2.6838
$6.1683
Lipocine Inc Stock (LPCN) Company Profile
Nome
Lipocine Inc
Settore
Industria
Telefono
801 994 7383
Indirizzo
675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, UT
Confronta LPCN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LPCN
Lipocine Inc
|
3.027 | 16.34M | 0 | -16.35M | -11.88M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Lipocine Inc Stock (LPCN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-06-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-12-10 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2018-01-12 | Reiterato | H.C. Wainwright | Buy |
| 2018-01-11 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2017-12-08 | Ripresa | H.C. Wainwright | Buy |
| 2016-10-07 | Iniziato | H.C. Wainwright | Buy |
| 2015-07-22 | Iniziato | ROTH Capital | Buy |
| 2015-06-23 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Lipocine Inc Borsa (LPCN) Ultime notizie
Can technical indicators confirm Lipocine Inc.’s reversalJuly 2025 Macro Moves & Entry and Exit Point Strategies - Newser
Is Lipocine Inc. vulnerable to short sellersJuly 2025 Sector Moves & Risk Controlled Daily Trade Plans - thegnnews.com
Combining price and volume data for Lipocine Inc.CEO Change & Verified Short-Term Plans - Newser
Advanced analytics toolkit walkthrough for Lipocine Inc.Weekly Trade Summary & Weekly High Return Forecasts - Newser
Visualizing Lipocine Inc. stock with heatmapsRecession Risk & Weekly Momentum Stock Picks - Newser
Visual analytics tools that track Lipocine Inc. performanceIndex Update & Low Drawdown Trading Techniques - Newser
Real time alert setup for Lipocine Inc. performanceOptions Play & Verified Momentum Stock Watchlist - Newser
Moving Average Trends for Lipocine Inc. Stock: What They IndicateDollar Strength & Fast Gain Stock Trading Tips - Newser
Pattern recognition hints at Lipocine Inc. upsidePortfolio Risk Report & Weekly Chart Analysis and Trade Guides - Newser
What the charts say about Lipocine Inc. today2025 Technical Overview & Fast Entry High Yield Stock Tips - Newser
Multi factor analysis applied to Lipocine Inc.Weekly Stock Analysis & AI Driven Stock Movement Reports - Newser
Lipocine (NASDAQ:LPCN) Upgraded at Alliance Global Partners - Defense World
What machine learning models say about Lipocine Inc.Portfolio Performance Summary & Long-Term Capital Growth Ideas - Newser
Lipocine Inc. stock trend outlook and recovery pathJuly 2025 Pullbacks & Verified Chart Pattern Signals - Newser
Is Lipocine Inc. reversing from oversold territoryChart Signals & Reliable Price Action Trade Plans - Newser
Tools to assess Lipocine Inc.’s risk profileCommunity Picked Stocks with Trade Insights - Newser
Lipocine to Host Virtual R&D Investor Event to Discuss LPCN 1154 (BRLIZIO) as a Treatment for Postpartum Depression on July 9, 2025 - 富途牛牛
When is the best time to exit Lipocine Inc.Historical Volatility and Pattern Breakdown Analysis - Newser
Postpartum Depression Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | GH Research, Reunion Neuroscience, Lipocine, Brii Biosciences Limited - Barchart.com
What earnings revisions data tells us about Lipocine Inc.AI Trend Detection for Entry Timing - Newser
Detecting support and resistance levels for Lipocine Inc.Daily Market Entry Strategy with Tools - Newser
What makes Lipocine Inc. stock price move sharplySwing Candidate List with Trade Cues - Newser
Lipocine Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingBull Market Summary and Recovery Outlook - Newser
Lipocine (LPCN) Projected to Post Earnings on Thursday - Defense World
Lipocine: Q2 Earnings Snapshot - New Haven Register
Lipocine Inc. Reports Q2 2025 Financial Results - TipRanks
Lipocine Inc.’s volatility index tracking explainedWeekly Price Target Forecast and Alerts - Newser
Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2025 - PR Newswire
Lipocine Reports 29% Smaller Loss as PPD Drug Trial Progresses, Targets $70B GLP-1 Market - Stock Titan
Lipocine Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
What is Lipocine Inc. company’s growth strategyRapid-fire capital growth - Jammu Links News
What analysts say about Lipocine Inc. stockMaximize portfolio growth with strategic plans - Jammu Links News
What drives Lipocine Inc. stock priceAchieve rapid portfolio growth with smart picks - Jammu Links News
Lipocine Inc Azioni (LPCN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.44%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):